Evidence map›Paper›PMID 31959624›Full record

ArticleLife science alliance2020

Nup93 regulates breast tumor growth by modulating cell proliferation and actin cytoskeleton remodeling.

Simone Bersini, Nikki K Lytle, Roberta Schulte, Ling Huang, Geoffrey M Wahl, Martin W Hetzer

Open access · goldAbstract read
In one paragraph

Article in Life science alliance, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 33 papers.

0numbers the graph read from it
0cells of the map it votes in
33citing papers in PubMed
3.3field-weighted citation impact, top 7% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

33 citing papers in PubMed, 54 citations in OpenAlex.

  1. International journal of molecular sciences · 2026
    Review
  2. Article
  3. Article
  4. Article
  5. Article
  6. Article
  7. Article
  8. Article
  9. Article
  10. Article
  11. Advances in the understanding of nuclear pore complexes in human diseases.Journal of cancer research and clinical oncology · 2024
    Review
  12. Article
  13. Article
  14. Article
  15. Review
  16. The role ofLife science alliance · 2023
    Article
  17. Article
  18. Article
  19. A rare cause of steroid-resistant nephrotic syndrome - a case report.Central-European journal of immunology · 2023
    Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors at 1 institution in 1 country.

Simone BersiniMolecular and Cell Biology Laboratory, The Salk Institute for Biological Studies, La Jolla, CA, USA.
Nikki K LytleLaboratory of Genetics, The Salk Institute for Biological Studies, La Jolla, CA, USA.
Roberta SchulteMolecular and Cell Biology Laboratory, The Salk Institute for Biological Studies, La Jolla, CA, USA.
Ling HuangThe Razavi Newman Integrative Genomics and Bioinformatics Core (IGC), The Salk Institute for Biological Studies, La Jolla, CA, USA.
Geoffrey M WahlLaboratory of Genetics, The Salk Institute for Biological Studies, La Jolla, CA, USA.
Martin W HetzerMolecular and Cell Biology Laboratory, The Salk Institute for Biological Studies, La Jolla, CA, USA hetzer@salk.edu.ORCID 0000-0002-2111-992X
Salk Institute for Biological Studies · US

Funding

Viral Vector Core (VVC)P30CA014195 · NCI · SALK INSTITUTE FOR BIOLOGICAL STUDIES · PI Reuben Shaw · 1985 to 2026
$82.8M
Salk Institute Cancer Training GrantT32CA009370 · NCI · SALK INSTITUTE FOR BIOLOGICAL STUDIES · PI Diana Clare Hargreaves, Jan Karlseder · 1986 to 2026
$8.6M
Combining single cell approaches and a developmental perspective to discover stem cell control circuits and the cellular and molecular bases of cancer heterogeneityR35CA197687 · NCI · SALK INSTITUTE FOR BIOLOGICAL STUDIES · PI WAHL, GEOFFREY MYLES · 2015 to 2021
$7.8M
The role of long-lived proteins in the survival of nerve cellsR01NS096786 · NINDS · SALK INSTITUTE FOR BIOLOGICAL STUDIES · PI HETZER, MARTIN W · 2015 to 2019
$3.6M
Mechanisms of nucleoporin-mediated gene regulationR01GM126829 · NIGMS · SALK INSTITUTE FOR BIOLOGICAL STUDIES · PI HETZER, MARTIN W · 2018 to 2021
$1.6M
NCI NIH HHS P30 CA014195NCI NIH HHS R35 CA197687NCI NIH HHS T32 CA009370NIGMS NIH HHS R01 GM126829NINDS NIH HHS R01 NS096786
6 · The paper itself

Abstract

Nucleoporin 93 (Nup93) expression inversely correlates with the survival of triple-negative breast cancer patients. However, our knowledge of Nup93 function in breast cancer besides its role as structural component of the nuclear pore complex is not understood. Combination of functional assays and genetic analyses suggested that chromatin interaction of Nup93 partially modulates the expression of genes associated with actin cytoskeleton remodeling and epithelial to mesenchymal transition, resulting in impaired invasion of triple-negative, claudin-low breast cancer cells. Nup93 depletion induced stress fiber formation associated with reduced cell migration/proliferation and impaired expression of mesenchymal-like genes. Silencing

Indexed as

LIM Domain ProteinsActin CytoskeletonCarcinogenesisCell LineCell Line, TumorCell ProliferationChromatinEpithelial-Mesenchymal TransitionFemaleGene Expression Regulation, NeoplasticHumansNuclear PoreNuclear Pore Complex ProteinsRNA InterferenceTriple Negative Breast NeoplasmsChromatinLIMCH1 protein, humanLIM Domain ProteinsNuclear Pore Complex ProteinsNup93 protein, human

Identifiers

PMID31959624
PMCPMC6971368
OpenAlexW3000973906

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.